FDA OKs First Drug for Aggressive, Ultra-Rare Sarcoma
Nab-sirolimus approved for locally advanced unresectable or metastatic malignant PEComa
Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nab-sirolimus approved for locally advanced unresectable or metastatic malignant PEComa
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on...
/PRNewswire/ -- Aerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in...
NEW YORK, June 10, 2021 -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights...
/PRNewswire/ -- Aerpio Pharmaceuticals, Inc. (NasdaqCM: ARPO) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in...